Search research articles
Contact Us
Filters
Showing results (151-160 of 190) with videos related to
Page
of 19
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
November 11, 2020
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur
Jennifer Swainson, Alexander McGirr, Pierre Blier, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
November 18, 2025
The Canadian Network for Mood and Anxiety Treatments Task Force Recommendations for the Use of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplants in Adults With Major Depressive Disorder: Recommandations du Groupe de travail du Réseau canadien pour le traitement des troubles de l'humeur et de l'anxiété (Canadian Network for Mood and Anxiety Treatments, CANMAT) concernant l'utilisation des probiotiques, des prébiotiques, des symbiotiques et de la transplantation de microbiote fécal chez les adultes atteints de trouble dépressif majeur
Anees Bahji, Elisa Brietzke, Noah C A Cooke, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
July 24, 2025
Standardized EEG for multi-site biomarker-informed trials: Implementation in the Canadian Biomarker Integration Network in Depression
Benjamin Schwartzmann, Prabhjot Dhami, Raaj Chatterjee, et al.
Journal of Affective Disorders
|
November 24, 2017
The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study
Anusha Baskaran, Faranak Farzan, Roumen Milev, et al.
Translational Psychiatry
|
September 6, 2022
Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
Farhana Islam, Victoria S Marshe, Leen Magarbeh, et al.
The Journal of Clinical Psychiatry
|
May 16, 2019
Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment
Raoul Belzeaux, Laura M Fiori, Juan Pablo Lopez, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
August 17, 2022
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder
Joshua D Rosenblat, M Ishrat Husain, Yena Lee, et al.
Scientific Reports
|
September 15, 2023
A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study
Anastasiya Slyepchenko, Rudolf Uher, Keith Ho, et al.
Journal of Affective Disorders
|
December 24, 2023
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression
Sagar V Parikh, Jennifer L Vande Voort, Anastasia K Yocum, et al.
Translational Psychiatry
|
October 10, 2019
Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants
Chelsey Ju, Laura M Fiori, Raoul Belzeaux, et al.
Page
of 19
Search research articles
Search
Showing results (151-160 of 190) with videos related to
Sort By:
Page
of 19
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
November 11, 2020
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Réseau Canadien Pour Les Traitements De L'humeur Et De L'anxiété (Canmat) Concernant L'utilisation De La Kétamine Racémique Chez Les Adultes Souffrant De Trouble Dépressif Majeur
Jennifer Swainson, Alexander McGirr, Pierre Blier, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
November 18, 2025
The Canadian Network for Mood and Anxiety Treatments Task Force Recommendations for the Use of Probiotics, Prebiotics, Synbiotics, and Fecal Microbiota Transplants in Adults With Major Depressive Disorder: Recommandations du Groupe de travail du Réseau canadien pour le traitement des troubles de l'humeur et de l'anxiété (Canadian Network for Mood and Anxiety Treatments, CANMAT) concernant l'utilisation des probiotiques, des prébiotiques, des symbiotiques et de la transplantation de microbiote fécal chez les adultes atteints de trouble dépressif majeur
Anees Bahji, Elisa Brietzke, Noah C A Cooke, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
July 24, 2025
Standardized EEG for multi-site biomarker-informed trials: Implementation in the Canadian Biomarker Integration Network in Depression
Benjamin Schwartzmann, Prabhjot Dhami, Raaj Chatterjee, et al.
Journal of Affective Disorders
|
November 24, 2017
The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study
Anusha Baskaran, Faranak Farzan, Roumen Milev, et al.
Translational Psychiatry
|
September 6, 2022
Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
Farhana Islam, Victoria S Marshe, Leen Magarbeh, et al.
The Journal of Clinical Psychiatry
|
May 16, 2019
Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment
Raoul Belzeaux, Laura M Fiori, Juan Pablo Lopez, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
August 17, 2022
The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder
Joshua D Rosenblat, M Ishrat Husain, Yena Lee, et al.
Scientific Reports
|
September 15, 2023
A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study
Anastasiya Slyepchenko, Rudolf Uher, Keith Ho, et al.
Journal of Affective Disorders
|
December 24, 2023
Clinical outcomes in the biomarkers of ketamine (Bio-K) study of open-label IV ketamine for refractory depression
Sagar V Parikh, Jennifer L Vande Voort, Anastasia K Yocum, et al.
Translational Psychiatry
|
October 10, 2019
Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants
Chelsey Ju, Laura M Fiori, Raoul Belzeaux, et al.
Page
of 19